In this issue:
Interdisciplinary weight loss and lifestyle intervention for OSA
Benralizumab for chronic rhinosinusitis with nasal polyps
Inhaled NO for fibrotic ILD requiring oxygen
Nintedanib for progressive fibrosing ILD
Health problems beyond pulmonary recovery after COVID-19 hospitalisation
Morbidity and mortality associated with air pollution above US standards
European guidelines for HFNC in acute respiratory failure
Chronic respiratory symptoms and incident CV disease/all-cause mortality
Impact of diet during pregnancy on children’s respiratory outcomes
Please login below to download this issue (PDF)